Skip to content
Riskpilot
← Back to search
Sign in
Get full access
KEMIFARMA Consulting ApS
APS
Active
CVR 34709955
Birkholmsvej 23, 2800
Kongens Lyngby
Engineering activities and related technical consultancy
·
NACE 7112
Est. 2012 · 13 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Engineering activities and related technical consultancy
/
KEMIFARMA Consulting ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
1M
2022
1M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-122
1.088
1.389
-97
-57
Staff expenses
-0
-784
-1.119
-1
-0
EBITDA
-122
305
312
-98
-57
Depreciation & amort.
-59
-59
21
-0
-0
EBIT
-181
246
291
-98
-57
Net financials
680
18
556
-220
632
Profit before tax
499
264
847
-318
575
Tax
89
74
184
61
33
Net profit
410
189
663
-379
541
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
3.168
3.483
3.963
3.145
3.434
Equity
3.149
3.338
3.751
3.123
3.414
Long-term debt
0
0
0
0
0
Short-term debt
16
142
212
22
20
Total debt
16
142
212
22
20
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-5746900.0%
This company
2021
2025
Equity ratio
99.4%
This company
38.2%
Market median
+160% vs market
2021
2025
Return on equity
15.9%
This company
18.4%
Market median
+14% vs market
2021
2025
Net profit margin (of gross profit)
54138500.0%
This company
2021
2025
Asset turnover (of gross profit)
-0.02×
This company
2021
2025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on KEMIFARMA Consulting ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
